Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Pseudolinear C4d deposits in a hereditary glomerulopathy caused by a rare NC1 collagen-4-alpha-5 missense mutation: a "new disease entity"?

Roy S, Nalwa A, Keith J, Weck K, Singh H, Nickeleit V.

Ultrastruct Pathol. 2019 Nov 4:1-7. doi: 10.1080/01913123.2019.1683666. [Epub ahead of print]

PMID:
31682783
2.

The two-faced nature of BK polyomavirus: lytic infection or non-lytic large-T-positive carcinoma.

Nickeleit V, Singh HK, Kenan DJ, Mieczkowski PA.

J Pathol. 2018 Sep;246(1):7-11. doi: 10.1002/path.5127. Epub 2018 Jul 31.

3.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

4.

Antibodies Can Extenuate Polyomavirus Infections.

Nickeleit V, Singh HK, Rivier LH.

J Am Soc Nephrol. 2018 May;29(5):1577. doi: 10.1681/ASN.2017111211. Epub 2018 Feb 21. No abstract available.

5.

The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.

Nickeleit V, Singh HK, Randhawa P, Drachenberg CB, Bhatnagar R, Bracamonte E, Chang A, Chon WJ, Dadhania D, Davis VG, Hopfer H, Mihatsch MJ, Papadimitriou JC, Schaub S, Stokes MB, Tungekar MF, Seshan SV; Banff Working Group on Polyomavirus Nephropathy.

J Am Soc Nephrol. 2018 Feb;29(2):680-693. doi: 10.1681/ASN.2017050477. Epub 2017 Dec 26.

6.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

7.

C4d-expressing glomerulopathy and proteinuria post transplantation of a too-big-for-size mismatched kidney allograft: An unusual case with good outcome
.

Gougeon F, Mikhailov AV, Gibson K, Kozlowski T, Singh HK, Nickeleit V.

Clin Nephrol. 2017 Dec;88(12):364-370. doi: 10.5414/CN109296.

PMID:
28933341
8.

Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.

O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-623. doi: 10.2215/CJN.10871016. Epub 2017 Mar 21.

9.

Fatal proteinuric kidney disease in a 30-month-old German Fleckvieh heifer caused by unilateral focal segmental glomerulosclerosis subsequent to a non-functional counterpart kidney.

Breuer W, Nickeleit V, Metzner M, Knubben-Schweizer G, Hafner-Marx A.

Schweiz Arch Tierheilkd. 2017 Mar;159(3):179-184. doi: 10.17236/sat00110.

10.

Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.

Gasim AH, Chua JS, Wolterbeek R, Schmitz J, Weimer E, Singh HK, Nickeleit V.

Transpl Int. 2017 May;30(5):519-532. doi: 10.1111/tri.12936. Epub 2017 Mar 23.

11.

Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.

Payan Schober F, Jobson MA, Poulton CJ, Singh HK, Nickeleit V, Falk RJ, Jennette JC, Nachman PH, Pendergraft Iii WF.

Am J Nephrol. 2017;45(3):248-256. doi: 10.1159/000455390. Epub 2017 Feb 4.

12.

BK Polyomavirus Genomic Integration and Large T Antigen Expression: Evolving Paradigms in Human Oncogenesis.

Kenan DJ, Mieczkowski PA, Latulippe E, Côté I, Singh HK, Nickeleit V.

Am J Transplant. 2017 Jun;17(6):1674-1680. doi: 10.1111/ajt.14191. Epub 2017 Feb 21.

13.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

14.

Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy.

Xu L, Hiller S, Simington S, Nickeleit V, Maeda N, James LR, Yi X.

PLoS One. 2016 Oct 5;11(10):e0163208. doi: 10.1371/journal.pone.0163208. eCollection 2016.

15.

Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients.

Burger-Calderon R, Ramsey KJ, Dolittle-Hall JM, Seaman WT, Jeffers-Francis LK, Tesfu D, Nickeleit V, Webster-Cyriaque J.

Virology. 2016 Jun;493:255-66. doi: 10.1016/j.virol.2016.03.020. Epub 2016 Apr 14.

16.

Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?

Becker JU, Chang A, Nickeleit V, Randhawa P, Roufosse C.

Am J Transplant. 2016 Sep;16(9):2654-60. doi: 10.1111/ajt.13784. Epub 2016 May 5.

17.

The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study.

Laskin BL, Singh HK, Beier UH, Moatz T, Furth SL, Bunin N, Witte D, Goebel J, Davies SM, Dandoy C, Jodele S, Nickeleit V.

Transplantation. 2016 Oct;100(10):e81-7. doi: 10.1097/TP.0000000000001085.

18.

Renal allograft biopsies: a guide of ins and outs for best results.

Nickeleit V.

Cesk Patol. 2015;51(4):181-6. Review.

PMID:
26585109
19.

The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome.

Kenan DJ, Mieczkowski PA, Burger-Calderon R, Singh HK, Nickeleit V.

J Pathol. 2015 Nov;237(3):379-89. doi: 10.1002/path.4584. Epub 2015 Aug 19.

20.

Polyomaviruses and disease: is there more to know than viremia and viruria?

Nickeleit V, Singh HK.

Curr Opin Organ Transplant. 2015 Jun;20(3):348-58. doi: 10.1097/MOT.0000000000000192. Review.

21.

Bile cast nephropathy.

Jain K, Gupta A, Singh HK, Nickeleit V, Kshirsagar AV.

Kidney Int. 2015 Feb;87(2):484. doi: 10.1038/ki.2014.233. No abstract available.

22.

Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease.

Singh HK, Reisner H, Derebail VK, Kozlowski T, Nickeleit V.

Transplantation. 2015 Mar;99(3):609-15. doi: 10.1097/TP.0000000000000367.

23.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee.

Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590. Erratum in: Am J Transplant. 2015 Oct;15(10):2784. Rangel, Erika [corrected to Rangel, Erika B].

24.

BK virus-associated urinary bladder carcinoma in transplant recipients: productive or nonproductive polyomavirus infections in tumor cells?

Nickeleit V, Singh HK, Goldsmith CS, Miller SE, Kenan DJ.

Hum Pathol. 2013 Dec;44(12):2870-1. doi: 10.1016/j.humpath.2013.08.017. No abstract available.

25.

Replication of oral BK virus in human salivary gland cells.

Burger-Calderon R, Madden V, Hallett RA, Gingerich AD, Nickeleit V, Webster-Cyriaque J.

J Virol. 2014 Jan;88(1):559-73. doi: 10.1128/JVI.02777-13. Epub 2013 Oct 30.

26.

Foretelling the future: predicting graft outcome by evaluating kidney baseline transplant biopsies.

Nickeleit V.

J Am Soc Nephrol. 2013 Nov;24(11):1716-9. doi: 10.1681/ASN.2013070761. Epub 2013 Aug 29. No abstract available.

27.

Polyomavirus-associated nephritis in 2 horses.

Jennings SH, Wise AG, Nickeleit V, Maes RK, Cianciolo RE, Del Piero F, Law JM, Kim Y, McCalla AC, Breuhaus BA, Roberts MC, Linder KE.

Vet Pathol. 2013 Sep;50(5):769-74. doi: 10.1177/0300985813476063. Epub 2013 Feb 4.

PMID:
23381926
28.

BK polyoma virus nephropathy in the native kidney.

Sharma SG, Nickeleit V, Herlitz LC, de Gonzalez AK, Stokes MB, Singh HK, Markowitz GS, D'Agati VD.

Nephrol Dial Transplant. 2013 Mar;28(3):620-31. doi: 10.1093/ndt/gfs537. Epub 2012 Dec 18.

PMID:
23249622
29.

Risk assessment for polyomavirus nephropathy using urine cytology and the detection of decoy cells: cheap and efficient.

Nickeleit V, True K, Detwiler R, Kozlowski T, Singh H.

Transplantation. 2012 Oct 15;94(7):e42-4; author reply e45. doi: 10.1097/TP.0b013e31826784d8. No abstract available.

PMID:
23197131
30.

Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited.

Liapis G, Singh HK, Derebail VK, Gasim AM, Kozlowski T, Nickeleit V.

Transplantation. 2012 Sep 27;94(6):620-9.

31.

Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.

Gilbert MR, Wagner NJ, Jones SZ, Wisz AB, Roques JR, Krum KN, Lee SR, Nickeleit V, Hulbert C, Thomas JW, Gauld SB, Vilen BJ.

J Immunol. 2012 Jul 15;189(2):711-20. doi: 10.4049/jimmunol.1102973. Epub 2012 Jun 6.

32.

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.

Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.

Clin J Am Soc Nephrol. 2012 Jun;7(6):914-25. doi: 10.2215/CJN.11751111. Epub 2012 Mar 29.

33.

Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.

Kozlowski T, Andreoni K, Schmitz J, Hayashi PH, Nickeleit V.

Liver Transpl. 2012 Jun;18(6):641-58. doi: 10.1002/lt.23403.

34.

Pros and cons for C4d as a biomarker.

Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, Zhao MH, Bruijn JA, Bajema IM.

Kidney Int. 2012 Apr;81(7):628-39. doi: 10.1038/ki.2011.497. Epub 2012 Feb 1. Review.

35.

Reduced expression of lipoic acid synthase accelerates diabetic nephropathy.

Yi X, Xu L, Hiller S, Kim HS, Nickeleit V, James LR, Maeda N.

J Am Soc Nephrol. 2012 Jan;23(1):103-11. doi: 10.1681/ASN.2011010003. Epub 2011 Oct 21.

36.

Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies.

Kozlowski T, Rubinas T, Nickeleit V, Woosley J, Schmitz J, Collins D, Hayashi P, Passannante A, Andreoni K.

Liver Transpl. 2011 Apr;17(4):357-68. doi: 10.1002/lt.22233.

37.

Donor-transmitted adenovirus infection causing kidney allograft nephritis and graft loss.

Kozlowski T, Nickeleit V, Andreoni K.

Transpl Infect Dis. 2011 Apr;13(2):168-73. doi: 10.1111/j.1399-3062.2010.00572.x. Epub 2010 Sep 13.

PMID:
20854282
38.

α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy.

Yi X, Nickeleit V, James LR, Maeda N.

J Diabetes Complications. 2011 May-Jun;25(3):193-201. doi: 10.1016/j.jdiacomp.2010.07.004. Epub 2010 Aug 30.

39.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A.

Am J Transplant. 2010 Mar;10(3):464-71. doi: 10.1111/j.1600-6143.2009.02987.x. Epub 2010 Jan 29.

40.

Viral Haufen are urinary biomarkers of polyomavirus nephropathy: New diagnostic strategies utilizing negative staining electron microscopy.

Singh HK, Donna Thompson B, Nickeleit V.

Ultrastruct Pathol. 2009 Oct;33(5):222-35. doi: 10.3109/01913120903241081.

PMID:
19895295
41.

Pathology: donor biopsy evaluation at time of renal grafting.

Nickeleit V.

Nat Rev Nephrol. 2009 May;5(5):249-51. doi: 10.1038/nrneph.2009.50.

PMID:
19384322
42.

Cryoglobulinemia and glomerular rhomboid inclusions in a child with acute kidney injury.

Nester CM, Benner EJ, Latour M, Nickeleit V, Hamrick H, Primack W.

Am J Kidney Dis. 2009 May;53(5):866-70. doi: 10.1053/j.ajkd.2009.01.015. Epub 2009 Mar 20.

43.

Presence of urinary Haufen accurately predicts polyomavirus nephropathy.

Singh HK, Andreoni KA, Madden V, True K, Detwiler R, Weck K, Nickeleit V.

J Am Soc Nephrol. 2009 Feb;20(2):416-27. doi: 10.1681/ASN.2008010117. Epub 2009 Jan 21.

44.

Inflammatory cells in renal allografts.

Nickeleit V, Andreoni K.

Front Biosci. 2008 May 1;13:6202-13. Review.

PMID:
18508654
45.

Banff 07 classification of renal allograft pathology: updates and future directions.

Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M.

Am J Transplant. 2008 Apr;8(4):753-60. doi: 10.1111/j.1600-6143.2008.02159.x. Epub 2008 Feb 19.

46.

Radiofrequency ablation for selective reduction in the complicated monochorionic gestation.

Moise KJ Jr, Johnson A, Moise KY, Nickeleit V.

Am J Obstet Gynecol. 2008 Feb;198(2):198.e1-5. doi: 10.1016/j.ajog.2007.07.043.

PMID:
18226623
47.

Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy.

Bracamonte E, Leca N, Smith KD, Nicosia RF, Nickeleit V, Kendrick E, Furmanczyk PS, Davis CL, Alpers CE, Kowalewska J.

Am J Transplant. 2007 Jun;7(6):1552-60. Epub 2007 Apr 8.

48.

Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.

Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V.

Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. Epub 2007 Mar 29.

PMID:
17395652
49.

Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys.

Gottmann U, Mueller-Falcke A, Schnuelle P, Birck R, Nickeleit V, van der Woude FJ, Yard BA, Braun C.

Transpl Int. 2007 Jun;20(6):542-9. Epub 2007 Mar 9.

50.

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').

Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ.

Am J Transplant. 2007 Mar;7(3):518-26.

Supplemental Content

Loading ...
Support Center